SMS Pharmaceuticals Ltd — Board/Management Information 2023

May 17, 2023

==> picture [241 x 158] intentionally omitted <==

Date: 17[th] May, 2023

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Subject: Notice of Board Meeting & Intimation

With reference to the cited subject matter, we would like to inform you that a meeting of the Board of Directors of the Company scheduled to be held on Wednesday, 24[th] May, 2023 at the Registered Office of the Company situated at Plot No. 72, H.No. 8-2-334/3&4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad, Telangana 500034 inter alia to transact the following items:

• To consider and approve the Audited Financial Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2023.

• To consider, recommend dividend if any, for the financial year 2022-2023

In accordance with the Company’s Code of Conduct for Prevention of Insider Trading, pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has already intimated its designated persons including directors regarding the closure of the ‘Trading Window’ for trading in the Company's equity shares from 01[st] April, 2023, it will remain closed up to 26[th] May, 2023 (both days inclusive) and shall be re-opened on 27[th] May, 2023.

We request to kindly take note of the same

Thanking you

Yours faithfully

For SMS Pharmaceuticals Limited

Thirumalesh Digitally signed by Thirumalesh Tumma Tumma Date: 2023.05.17 18:43:10 +05'30' Thirumalesh Tumma Company Secretary